ATHX
|
Athersys, Inc.
|
US
|
NASDAQ
|
AXGN
|
AxoGen, Inc.
|
US
|
NASDAQ
|
AZYO
|
Aziyo Biologics, Inc.
|
US
|
NASDAQ
|
BCDA
|
BioCardia, Inc.
|
US
|
NASDAQ
|
BLFS
|
BioLife Solutions, Inc.
|
US
|
NASDAQ
|
BRTX
|
BioRestorative Therapies, Inc.
|
US
|
NASDAQ
|
CLGN
|
CollPlant Holdings, Ltd.
|
US
|
NASDAQ
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|
HSTO
|
Histogen Inc.
|
US
|
NASDAQ
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|
LSTA
|
Lisata Therapeutics, Inc.
|
US
|
NASDAQ
|
ORGO
|
Organogenesis Holdings Inc.
|
US
|
NASDAQ
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
PROK
|
ProKidney Corp.
|
US
|
NASDAQ
|
RCEL
|
Avita Medical Limited
|
US
|
NASDAQ
|
SFE
|
Safeguard Scientifics, Inc.
|
US
|
NASDAQ
|
VTGN
|
VistaGen Therapeutics, Inc.
|
US
|
NASDAQ
|
ARX
|
Aroa Biosurgery Limited
|
AU
|
ASX
|
AVR
|
Anteris Technologies Ltd
|
AU
|
ASX
|
CTE
|
Cryosite Limited
|
AU
|
ASX
|